iiinova — where your digital self keeps evolving

Reposted by Camila Coelho, PhD MBA

Waggoner Lab @labwaggoner.bsky.social · 14/04/2026

Preview @cp-immunity.bsky.social @camilahcoelho.bsky.social Universal vaccines? Only if your antibody genes agree www.cell.com/immunity/ful... @ki.se www.cell.com/immunity/ful... www.cell.com/immunity/ful...

131

Reposted by Camila Coelho, PhD MBA

Keystone Symposia @keystonesymposia.bsky.social · 29/05/2026

🔬 Fellow Spotlight: Dr. Camila Coelho @camilahcoelho.bsky.social Our latest Spotlight blog features Dr. Coelho's work decoding human B cell responses to emerging viruses — and her commitment to making science more accessible everywhere. Read more: keysym.us/CoelhoSpotli... #KSFellows #WIS

keysym.us

Keystone Symposia Fellow Spotlight: Dr. Camila Coelho

Explore Dr. Camila Coelho’s groundbreaking research on human immunology and her commitment to global health, mentorship, and accessible science.

021

Reposted by Camila Coelho, PhD MBA

CL Hellisen @clhellisen.com · 25/02/2026

The problem with the whole 'post a woman author you've read 5 books by' is how many women don't get a second book, let alone five. Anyway, carry on.

4732762267

Reposted by Camila Coelho, PhD MBA

Victorian Infection and Immunity Network @theviin.bsky.social · 20/02/2026

Incredibly grateful to hear a beautiful invited talk from Dr Camila Coelho @camilahcoelho.bsky.social from Mount Sinai, NY🗽, revealing the first monoclonal antibody protective against an orthopoxvirus, for developing drugs and vaccines against Mpox which urgently needs new therapies 💉✨ #lorneiandi

181

Camila Coelho, PhD MBA @camilahcoelho.bsky.social · 26/01/2026

What an honor! Thank you very much @aai.org, and I can't wait to see everyone in Boston!

030

Reposted by Camila Coelho, PhD MBA

Immunology Podcast @immunologypodcast.com · 12/11/2025

We have a new episode out! Dr. @camilahcoelho.bsky.social from Icahn School of Medicine talks about her lab’s work on mpox and other emerging viruses, her approach to #mentorship, and how her MBA education helps her in science. Listen now: bit.ly/43M7r4x

051

Reposted by Camila Coelho, PhD MBA

Science X / Phys.org @sciencex.bsky.social · 26/08/2025

Three monoclonal antibodies targeting the mpox virus protein A35 have shown strong protection against severe disease in laboratory and animal models, indicating potential for new therapeutic approaches. doi.org/g9zg4h

medicalxpress.com

Three potent human antibodies against mpox pave way for new protective therapies

A team from the Microbiology Department at the Icahn School of Medicine at Mount Sinai has discovered three powerful monoclonal antibodies from a person who had previously been infected with mpox (formerly known as monkeypox).

033

Reposted by Camila Coelho, PhD MBA

Waggoner Lab @labwaggoner.bsky.social · 27/08/2025

041

Reposted by Camila Coelho, PhD MBA

Waggoner Lab @labwaggoner.bsky.social · 27/08/2025

Human monoclonal antibodies targeting A35 protect from death caused by monkeypox virus @cellcellpress.bsky.social @carolilucas.bsky.social @vivianasimonlab.bsky.social @mschotsaert.bsky.social www.cell.com/cell/fulltex...

185

Reposted by Camila Coelho, PhD MBA

Goran Bajic @gogo-science.bsky.social · 26/08/2025

New paper from the Coelho lab with a modest contribution from us:

031

Reposted by Camila Coelho, PhD MBA

Camila Coelho, PhD MBA @camilahcoelho.bsky.social · 23/08/2025

Join us next Wednesday as we hear from the great work from the Ward lab!

001

Reposted by Camila Coelho, PhD MBA

Carolina Lucas @carolilucas.bsky.social · 26/08/2025

4/ Structural studies revealed all 3 mAbs target a highly conserved epitope in the A35 dimer groove, shared across orthopoxviruses. This explains their breadth and potency.

101

Reposted by Camila Coelho, PhD MBA

Carolina Lucas @carolilucas.bsky.social · 26/08/2025

7/ Together, our findings establish A35 as a critical therapeutic target for mpox and related orthopoxviruses, paving the way for next-generation antibody therapies and improved vaccines.

101

Reposted by Camila Coelho, PhD MBA

Carolina Lucas @carolilucas.bsky.social · 26/08/2025

🚨New Paper in Cell 🧵🔎 Happy to share our work led by the @camilahcoelho.bsky.social, on mAbs against mpox. We were very excited (and lucky!) to contribute to this collab. effort. 🦠“Human monoclonal antibodies targeting A35 protect from death caused by mpox”🦠 doi.org/10.1016/j.cell.2025.08.004

1275

Camila Coelho, PhD MBA @camilahcoelho.bsky.social · 23/08/2025

Join us next Wednesday as we hear from the great work from the Ward lab!

001

Reposted by Camila Coelho, PhD MBA

Line Brugière @linebrugiere.bsky.social · 22/08/2025

Such a great time at the #IUIS2025! Inspiring conferences by amazing scientists such as @belkaidlab.bsky.social @virusesimmunity.bsky.social @linterman.bsky.social. Also loved seeing rising stars like @camilahcoelho.bsky.social @marionbrunck.bsky.social. Thanks to James Allison for his lecture !! ❤️

283

Reposted by Camila Coelho, PhD MBA

La Jolla Institute for Immunology (LJI) @lji.org · 12/08/2025

Congratulations to former LJI trainee Dr. Camila Coelho (now at the Icahn School of Medicine at Mount Sinai)! 🎉 Dr. Coelho has been named a "Rising Star" by Union of Immunological Societies — an award for early-stage researchers who are revolutionizing the field! bit.ly/4mGyF3H #health #medicine

bit.ly

Camila Coelho, PhD, MBA, Named Rising Star by Union of Immunological Societies

042

Reposted by Camila Coelho, PhD MBA

Vishal Rao @vishalnrao.bsky.social · 07/06/2025

Had a great time presenting my PhD work so far in @camilahcoelho.bsky.social’s lab at the Keystone Vaccinology meeting! Grateful for the chance to share and learn alongside such an inspiring community of scientists! #KSVaccines25

181

Reposted by Camila Coelho, PhD MBA

Tiff Weinkopff @tiffweinkopff.bsky.social · 17/07/2025

Labels matter and they influence policy. Thank you to the brilliant @camilahcoelho.bsky.social for making us rethink our default scientific terms to take away the unintended stigma to create a safer space. People like you help change the world.

011

Reposted by Camila Coelho, PhD MBA

Carolina Lucas @carolilucas.bsky.social · 16/07/2025

We urge researchers, editors, and public health professionals to: – Reassess default epidemiological labels – Prioritize accuracy over legacy language – Center transmission routes, not identities #PublicHealth #Mpox #InfectiousDiseases #StigmaFreeScience

031

Camila Coelho, PhD MBA @camilahcoelho.bsky.social · 16/07/2025

Check our important piece below 👇! "We urge authors, reviewers, and editors to revise the default use of MSM as an epidemiological label. Our intention is not to dismiss important epidemiological context but to prevent the stigmatization of affected populations." @thelancetinfdis.bsky.social

thelancet.com

A call to move beyond MSM-centric framing in mpox research

The resurgence of mpox poses urgent public health challenges, and the scientific community has mobilised admirably to understand its transmission, immunity, and therapeutics.1,2 However, the language ...

044